Pyrroles
Medchemexpress LLC HY-101971 10mg Medchemexpress, AZ PFKFB3 26 CAS:1704740-52-2 Purity:>98%
Medchemexpress, HY-101971 10mg AZ PFKFB3 26 CAS:1704740-52-2 AZ PFKFB3 26 is a potent and selective inhibitor of the metabolic kinase PFKFB3 with an IC50 of 23 nM. AZ PFKFB3 26 inhibits PFKFB1 and PFKFB2 with IC50s of 2.06 and 0.384 μM, respectively. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Medchemexpress LLC HY-102028 2mg Medchemexpress, KY1220 CAS:292168-79-7 Purity:>98%
Medchemexpress, HY-102028 2mg KY1220 CAS:292168-79-7 KY1220 is a compound that destabilizes both β-catenin and Ras, via targeting the Wnt/β-catenin pathway; with an IC50 of 2.1 μM in HEK293 reporter cells. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
eMolecules 1211526-56-5 | 4-Bromo-2-chloro-3-fluoropyridine | MFCD16606306 | 1g
Ambeed | 1-Methyl-4-(2-methyl-4-(4455-tetramethyl-132-dioxaborolan-2-yl)phenyl)piperazine | 100mg | 628568390 | A428909 | 1310704-51-8 | MFCD22581616 | 316.250 | C18H29BN2O2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC Bromoenol lactone | 88070-98-8 | MFCD00270871 | ≥98.0% | 317.18 g/mol | C16H13BrO2 | 10 MG
Bromoenol lactone is a suicide-based, irreversible inhibitor of calcium-independent phospholipase A2 (iPLA2β) used in biochemical research. It inhibits iPLA2β with an IC50 of approximately 7 μM and has been reported to block antigen-stimulated mast cell exocytosis without affecting Ca2+ influx. The compound is supplied as a solid for laboratory preparation of stock solutions.
- Irreversible mechanism-based inhibitor of iPLA2β.
- Reported IC50 of approximately 7 μM.
- Useful for studying phospholipase A2-mediated signaling and mast cell exocytosis.
- Available as a solid suitable for solution preparation.
- Molecular weight 317.18 g/mol; molecular formula C16H13BrO2.
![eMolecules Pharmablock / benzyl N-[trans-4-fluoropyrrolidin-3-yl]carbamate / 25mg / 724442744 / PB06369 / / 1638761-20-2 / [null] / 476.525 / C24H30F2N4O4](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502458854.PNG-250.jpg)
eMolecules Pharmablock / benzyl N-[trans-4-fluoropyrrolidin-3-yl]carbamate / 25mg / 724442744 / PB06369 / / 1638761-20-2 / [null] / 476.525 / C24H30F2N4O4
Pharmablock / benzyl N-[trans-4-fluoropyrrolidin-3-yl]carbamate / 25mg / 724442744 / PB06369 / / 1638761-20-2 / [null] / 476.525 / C24H30F2N4O4
eMolecules 1052714-11-0 | Ambeed | Methyl 3-amino-5-fluoropicolinate | 100mg | 517260738 | A479504 | MFCD18259055 | 170.143 | C7H7FN2O2
ChemScene | 7-Chloro-6-fluorochroman-4-one | 100mg | 569146751 | CS-0131575 | 1092349-37-5 | 200.590 | C9H6ClFO2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
eMolecules 1-(4-Iodophenyl)pyrrole | 92636-36-7 | 5G | Purity: 95%
Combi-Blocks | 1-(4-Iodophenyl)pyrrole | 5G | 92636-36-7 | MFCD00052399
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
eMolecules 4880-88-0 | Medchem Express | Vinburnine | 100mg | 415688886 | HY-B1180 | MFCD00064309 | 294.398 | C19H22N2O
Medchem Express | DPM-1001 (trihydrochloride) | 5mg | 596366461 | HY-121515A | | 677.230 | C35H60Cl3N3O3
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
Medchemexpress LLC Pamicogrel | 101001-34-7 | 448.53 | 100 MG
Pamicogrel (KBT3022) is a cyclooxygenase (COX) inhibitor with platelet anti-aggregatory properties. It is currently under development by Kanebo for the treatment of chronic arterial occlusion and shows potential for both the prophylaxis and treatment of ischemic brain injury.
- Acts as a cyclooxygenase (COX) inhibitor
- Exhibits platelet anti-aggregatory properties
- Developed for chronic arterial occlusion
- Shows potential for prophylaxis of ischemic brain injury
- Shows potential for treatment of ischemic brain injury